# Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease

> **NCT07713875** · PHASE4 · NOT_YET_RECRUITING · sponsor: **James Bayley** · enrollment: 50 (estimated)

## Conditions studied

- Venous Thromboembolism (VTE)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Spine Metastasis

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT07713875
- **Lead sponsor:** James Bayley
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-11
- **Final completion:** 2027-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713875, "Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07713875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*